EUVIMEDEUVIMED entdecken
Crossref

Metformin versus pioglitazone in treatment of polycystic ovarian syndrome - A randomized control trial

Jahanara Ainuddin, Musfera Islam, Syeda Rabia, Waqas Ahmed Farooqui, Ashi Islam

Medicine and Clinical Science · 2020

DOI: 10.33425/2690-5191.1016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine and Clinical Science, 2020. Verfasst von Jahanara Ainuddin und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the efficacy of metformin versus pioglitazone in the treatment of polycystic ovarian syndrome.

Methods

A prospective randomized controlled trial with parallel assignment was conducted in the outpatient Gynecology clinic of Dow University Hospital and Mamji Hospital, Karachi, Pakistan.One hundred and twenty patients with polycystic ovarian syndrome were selected and randomized into two groups with 60 patients receiving metformin in dose of 500mg TDS and 60 receiving pioglitazone 30mg daily.Clinical and biochemical parameters were evaluated at recruitment and at six months after treatment.Data was entered and analyzed through SPSS version 21.

Results

Patients in both groups were Age and BMI matched.Significant reductions in fasting insulin levels, total testosterone and free androgen levels were found in both groups after treatment (p

Zitieren

APA

Ainuddin, J., Islam, M., Rabia, S., Farooqui, W. A., & Islam, A. (2020). Metformin versus pioglitazone in treatment of polycystic ovarian syndrome - A randomized control trial. Medicine and Clinical Science. https://doi.org/10.33425/2690-5191.1016

Vancouver

Ainuddin J, Islam M, Rabia S, Farooqui WA, Islam A. Metformin versus pioglitazone in treatment of polycystic ovarian syndrome - A randomized control trial. Medicine and Clinical Science. 2020. doi:10.33425/2690-5191.1016

BibTeX
@article{Ainuddin2020,
  author = {Ainuddin, Jahanara and Islam, Musfera and Rabia, Syeda and Farooqui, Waqas Ahmed and Islam, Ashi},
  title = {Metformin versus pioglitazone in treatment of polycystic ovarian syndrome - A randomized control trial},
  journal = {Medicine and Clinical Science},
  year = {2020},
  doi = {10.33425/2690-5191.1016}
}
Kostenlos starten →